Novo Nordisk invests €432M ($506M) in Athlone, Ireland to boost oral glucagon-like peptide-1 manufacturing capacity for global markets by 2028.

These promotions highlight the momentum we’re seeing at CMC Virginia and the growth opportunities for our team,” said John Tsitos, branch president. “Ridge, Jose, and Candice have earned the trust of ...

Investors are differentiating between sectors facing immediate operational headwinds and those finding structural support in the flight to safety Read more at The Business Times.

Pharmaceutical company Novo Nordisk has announced a €430m expansion of its manufacturing operation in Athlone which will see it produce the tablet form of its weight loss drug Wegovy.

The impact depends on how the conflict plays out as well as whether markets have accumulated enough fundamental strength, say ...

Exclusive reporting on Munster, national and international business news and how it impacts Ireland and the poeple who live ...

Bagsværd, Denmark, 2 March 2026 - Novo Nordisk today announced an investment of 432 million euro (approx. DKK 3.2 billion) in ...

Ghana Limited has proposed a set of measures, including increased local processing and strengthened forward sales strategies, to stabilise Ghana’s cocoa sector. Some key proposals, contained in a ...

Nigeria’s net external reserves surged by 772.18% in two years to $34.80 billion at the end of 2025 from $3.99 billion in 2023, ...

Ardena, a specialist pharmaceutical contract development and manufacturing organizatin (CDMO) and bioanalytical ...

Comercio Partners has projected that the naira could strengthen to as high as N1,200 per dollar in the first half ...

Q4 2025 Earnings Call March 2, 2026 4:30 PM ESTCompany ParticipantsTimothy Lee - Head of Investor RelationWilliam Greenman ...